uniQure (QURE) Total Non-Current Liabilities (2015 - 2026)

uniQure (QURE) recorded quarterly Total Non-Current Liabilities of $570.2 million in Q1 2026, up 1.26% quarter-over-quarter from $563.1 million in Q4 2025, and up 6.49% on a YoY basis from $535.4 million in Q1 2025.

uniQure (QURE) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends

uniQure's Total Non-Current Liabilities history runs 12 years deep, the most recent figure standing at $570.2 million for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities rose 6.49% year-over-year to $570.2 million; the TTM figure through Mar 2026 stood at $570.2 million (up 6.49% YoY), while the FY2025 annual figure was $563.1 million, up 7.62% from the prior year.
  • Total Non-Current Liabilities was $570.2 million for Q1 2026 at uniQure, up from $563.1 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $570.2 million in Q1 2026 to a low of $151.9 million in Q1 2023.
  • Historically, Total Non-Current Liabilities has averaged $431.0 million across 5 years, with a median of $534.2 million in 2023.
  • The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities retreated 13.36% in 2022, then soared 268.55% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $153.0 million in 2022, then soared by 259.62% to $550.3 million in 2023, then fell by 4.93% to $523.2 million in 2024, then advanced by 7.62% to $563.1 million in 2025, then gained by 1.26% to $570.2 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $570.2 million (Q1 2026), $563.1 million (Q4 2025), and $559.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 uniQure 2.88 Bn 2.88 Bn 3.34 Mn 570.17 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 570.17 Mn
Dec 31, 2025 563.09 Mn
Sep 30, 2025 559.00 Mn
Jun 30, 2025 547.96 Mn
Mar 31, 2025 535.41 Mn
Dec 31, 2024 523.24 Mn
Sep 30, 2024 518.71 Mn
Jun 30, 2024 553.27 Mn
Mar 31, 2024 559.82 Mn
Dec 31, 2023 550.34 Mn
Sep 30, 2023 534.16 Mn
Jun 30, 2023 521.09 Mn
Mar 31, 2023 151.90 Mn
Dec 31, 2022 153.04 Mn
Sep 30, 2022 153.09 Mn
Jun 30, 2022 166.46 Mn
Mar 31, 2022 166.45 Mn
Dec 31, 2021 176.64 Mn
Sep 30, 2021 141.95 Mn
Jun 30, 2021 104.56 Mn